Supplementary Methods from BGC 945, a Novel Tumor-Selective Thymidylate Synthase Inhibitor Targeted to α-Folate Receptor–Overexpressing Tumors
Open Access
- 30 March 2023
- other
- Published by American Association for Cancer Research (AACR)
Abstract
Supplementary Methods from BGC 945, a Novel Tumor-Selective Thymidylate Synthase Inhibitor Targeted to α-Folate Receptor–Overexpressing TumorsKeywords
This publication has 0 references indexed in Scilit: